Acute pancreatitis
Conditions
Interventions
Intervention group:Modified Jianpi Pill+Standard care
control group:Standard care
Sponsors
Chengdu Integrated TCM and Western Medical Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Recovery period patients with clinically moderate to severe acute pancreatitis who have reached dietary standards after treatment; (2) Age 18-75 years old, regardless of gender; (3) Intended to receive a combination of modified Jianpi Pill and routine fluid replacement therapy; (4) If other types of biological agents have been used, the time should exceed their 2-3 half-lives; (5) I have good compliance with the observation and treatment of researchers, have signed an informed consent form, agree to accept various treatment methods from the research group, and comply with the arrangement of the research group
Exclusion criteria
Exclusion criteria: (1) Mild pancreatic patients (2) Women of childbearing age who are pregnant, breastfeeding, or have a recent pregnancy plan. (3) Individuals who are allergic to traditional Chinese medicine or other ingredients in the drug. (4) Active tuberculosis, hepatitis B or other serious infectious diseases. (5) Individuals with a history of tumors. (6) Severe diseases of important organs such as the heart, lungs, liver, kidneys, as well as neurological and psychiatric disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall clinical effectiveness;Laboratory Examination;Traditional Chinese Medicine Syndrome Score;Adverse reactions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization time during recovery period;Health evaluation;Recurrence rate;gastrointestinal function; | — |
Countries
China
Contacts
Public ContactHongmei Ran
Chengdu Integrated TCM and Western Medical Hospital
Outcome results
None listed